发明名称 New pyrido[3',2':4,5]furo[3,2-d]pyrimidine deratives
摘要 The present disclosure relates to a pyridofuropyrimidine derivative of formula (I): wherein G<SUP>1 </SUP>is a group chosen from -CR<SUP>6</SUP>R<SUP>7</SUP>- and -O- wherein R<SUP>6 </SUP>and R<SUP>7 </SUP>are independently chosen from hydrogen atoms and C<SUB>1-4 </SUB>alkyl groups; R<SUP>1 </SUP>and R<SUP>2 </SUP>are independently chosen from hydrogen atoms and C<SUB>1-4 </SUB>alkyl groups; R<SUP>3 </SUP>is chosen from C<SUB>1-4 </SUB>alkyl, C<SUB>1-4 </SUB>alkoxy, amino, hydroxy, mono-C<SUB>1-4</SUB>alkylamino, di-C<SUB>1-4</SUB>alkylamino, C<SUB>3-8</SUB>cycloalkylamino, aryl, heteroaryl and saturated N-containing heterocyclyl groups which are bound to the pyridine ring through their nitrogen atom, all of them being optionally substituted by one or more substituents chosen from halogen atoms and hydroxy, C<SUB>1-4 </SUB>alkyl, C<SUB>1-4</SUB>alkoxy-C<SUB>1-4</SUB>alkyl, aryl-C<SUB>1-4</SUB>alkyl, -O(CO)OR<SUP>8</SUP>, C<SUB>1-4 </SUB>alkoxy, -(CO)NR<SUP>8</SUP>R<SUP>9</SUP>, -CN, -CF<SUB>3</SUB>, -NR<SUP>8</SUP>R<SUP>9</SUP>, -SR<SUP>8 </SUP>and -SO<SUB>2</SUB>NH<SUB>2 </SUB>groups wherein R<SUP>8 </SUP>and R<SUP>9 </SUP>are each independently chosen from a hydrogen atom or a C<SUB>1-4 </SUB>alkyl group; R<SUP>4 </SUP>and R<SUP>5 </SUP>are independently chosen from hydrogen atoms, C<SUB>1-4</SUB>alkyl groups, hydroxyl-C<SUB>1-4</SUB>alkyl groups and groups of formula (II): wherein p and q are integers chosen from 0, 1, 2 and 3; A is either a direct bond or a group chosen from -CONR<SUP>14</SUP>-, -NR<SUP>14</SUP>CO-, -O-, -COO-, -OCO-, -S-, -SO- and -SO<SUB>2</SUB>-, wherein each R<SUP>10</SUP>, R<SUP>11</SUP>, R<SUP>12</SUP>, R<SUP>13 </SUP>and R<SUP>14 </SUP>are independently chosen from a hydrogen atom and a C<SUB>1-4</SUB>alkyl group and G<SUP>2 </SUP>is chosen from aryl, heteroaryl and heterocyclyl groups; wherein the group G<SUP>2 </SUP>is optionally substituted by one or more substituents chosen from halogen atoms and C<SUB>1-4</SUB>alkyl, hydroxy, oxo, C<SUB>1-4</SUB>alkoxy-C<SUB>1-4</SUB>alkyl, aryl-C<SUB>1-4</SUB>alkyl, -(CO)OR<SUP>16</SUP>, C<SUB>1-4</SUB>alkoxy, -(CO)NR<SUP>16</SUP>R<SUP>17</SUP>, -CN, -CF<SUB>3</SUB>, -NR<SUP>16</SUP>R<SUP>17</SUP>-SR<SUP>16 </SUP>and -SO<SUB>2</SUB>NH<SUB>2 </SUB>groups; wherein R<SUP>16 </SUP>and R<SUP>17 </SUP>each independently chosen from hydrogen atom and a C<SUB>1-4</SUB>alkyl group and the pharmaceutically acceptable salts and N-oxides thereof.
申请公布号 ZA200800352(B) 申请公布日期 2008.12.31
申请号 ZA20080000352 申请日期 2008.01.11
申请人 LABORATORIOS ALMIRALL, S.A. 发明人 TALTAVULL MOLL, JOAN;PAGES SANTACANA, LUIS MIQUEL
分类号 A61K;A61P;C07D 主分类号 A61K
代理机构 代理人
主权项
地址
您可能感兴趣的专利